Log in
Pharmacology · Drugs and Prescriptions

Oseltamivir

*Oseltamivir*

Oseltamivir is an antiviral drug and a prodrug. The drug blocks viral enzymes and is used for the treatment and prevention of influenza.

Pharmacological groupAntiviral agent, neuraminidase inhibitor
Spectrum of activityInfluenza virus types A and B
Therapeutic windowNo later than 48 hours after symptom onset
BioactivationLiver and intestinal esterases (prodrug)
How to write a prescription
Rp.: Caps. Oseltamiviri 0,075
D.t.d. N 10
S. Внутрь по 1 капсуле (0,075 г) 2 раза в сутки независимо от приёма пищи в течение 5 дней

Alternative prescription entries: Capsulas Oseltamiviri 0.075; Caps. Oseltamiviri 0.75; Caps. "Tamiflu" 0.075

Dosage form
Caps. 0.75 g
Administration
Orally, regardless of food intake, 0.75 g twice daily for 5 days
Group
Antiviral agents
3 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Mechanism of action

In chemical structure, Oseltamivir and its precursors are structural analogs of sialic acid. The drug's development was based on rational design by studying the neuraminidase-natural substrate complex.

During replication, new viral particles bud from the host cell membrane. Virion hemagglutinin binds to sialic acid residues on the cell surface, tethering the virus. The viral enzyme neuraminidase cleaves this bond, enabling virion detachment.

Oseltamivir acts as a neuraminidase inhibitor. By blocking this enzyme, the drug disrupts the release of new virions from the infected cell and prevents further spread of the infection.

Pharmacokinetics

The substance is administered orally and is well absorbed—the bioavailability of the active form reaches 80%. By nature, Oseltamivir is a prodrug (prodrug).

Upon entering the body, under the influence of hepatic and intestinal esterases, it is biotransformed into the active metabolite — oseltamivir carboxylate. This specific form provides the antiviral effect.

The drug is excreted by the kidneys unchanged (as carboxylate). The half-life ($t_{1/2}$) ranges from 6 to 10 hours.

Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Indications for use

The drug is prescribed for the specific treatment and prevention of influenza types A and B.

It is critically important to initiate therapeutic intake within the first 2 days (48 hours) from the onset of initial disease symptoms. The agent is also used for prophylaxis during seasonal epidemic outbreaks.

The drug is approved for adults and children over 1 year of age (for patients under 12 years, the dosage is calculated individually based on body weight).

Side effects and safety profile

The most pronounced adverse reactions when taking Oseltamivir are observed in the Central Nervous System (CNS):

  • insomnia;
  • ataxia (disorder of movement coordination);
  • impaired ability to concentrate;
  • other neuropsychiatric disorders.

Compared to other drugs in the class (e.g., M2 channel blockers rimantadine and amantadine), neuraminidase inhibitors have a different tolerability profile and show no cross-resistance to older agents.

Prescribing specifics and formulation

According to the reference guide rules, the dosage form is available in capsules of 0.75 g.

Standard administration regimen: 0.75 g twice daily orally, regardless of food intake, for a course of 5 days.

Unlike antibiotics or M2 channel blockers (rimantadine, effective only against influenza A), oseltamivir maintains high specificity for the neuraminidase of both major influenza types and is inactive against other viral infections like HIV.

How to memorize

OSELTAMIVIR = OSAL at the terminal (blocks the exit of the terminator virus from the cell at the 48th hour).

Class and exam questions

Why is oseltamivir called a prodrug?

Because the parent drug itself is inactive. Under the action of liver and intestinal esterases, it is converted into the active metabolite — oseltamivir carboxylate.

What is the main target enzyme blocked by oseltamivir?

The viral enzyme neuraminidase, responsible for detaching budded virions from sialic acids on the surface of the infected cell.

What is the treatment initiation timeframe for maximum efficacy?

Therapy must be initiated within the first 2 days (48 hours) after the onset of clinical influenza symptoms.

How is the active metabolite of the drug eliminated from the body?

Oseltamivir carboxylate is excreted by the kidneys unchanged, and its half-life is 6–10 hours.

Still have questions? Ask the AIThe AI tutor has read the material on "Oseltamivir" and will explain it in simple terms.

What else to study on this topic

  • Comparative analysis of zanamivir and oseltamivir as sialic acid analogs
  • Mechanisms of influenza virus resistance development to neuraminidase inhibitors
  • The role of hepatic and intestinal esterases in prodrug biotransformation
  • Differential pharmacotherapy of influenza: neuraminidase inhibitors vs. M2 channel blockers
  • Peculiarities of antiviral dosage calculation in children under 12 years of age

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Oseltamivir" and 5,304 other subject pages
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the «Drugs and Prescriptions» section

The entire "Drugs and Prescription" section

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.